Name: Terns Pharmaceuticals, Inc. (TERN) Balance Sheet
Creator: FinSpry

Terns Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Terns Pharmaceuticals, Inc. (TERN) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	161.44	263.44	143.24	47.70	74.85
Short-Term Investments	196.73	183.51	139.88	118.28	0.00
Cash & Short-Term Investments	358.16	263.44	283.11	165.98	74.85
Accounts Receivable	0.00	0.00	0.00	0.00	12.72
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	3.95	7.51	2.07	0.95	0.33
Total Current Assets	362.11	267.43	285.19	166.93	90.87
Non-Current Assets
Property, Plant & Equipment (Net)	1.47	1.03	1.80	1.05	1.18
Other Non-Current Assets	0.35	0.06	0.04	0.09	0.25
Total Non-Current Assets	1.82	1.09	1.84	1.14	1.42
Total Assets	363.93	268.52	287.03	168.07	92.29
Current Liabilities
Accounts Payable	2.15	2.52	1.65	2.13	7.45
Short-Term Debt	0.43	0.00	0.00	0.00	0.00
Accrued Liabilities	12.62	8.55	5.98	1.93	8.01
Other Current Liabilities	0.46	8.83	0.19	0.36	0.16
Total Current Liabilities	15.65	11.94	8.47	6.82	22.82
Non-Current Liabilities
Long-Term Debt	0.92	0.00	0.54	0.00	0.00
Other Non-Current Liabilities	1.49	1.21	1.07	0.95	0.88
Total Non-Current Liabilities	2.41	1.21	1.62	0.95	0.88
Total Liabilities	18.06	13.15	10.08	7.77	23.70
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.00	0.00
Retained Earnings	-421.48	-332.65	-242.42	-182.07	-131.92
Accumulated Other Comprehensive Income	-0.28	-0.02	-0.82	-0.34	-0.12
Additional Paid-in Capital	767.62	588.01	520.18	342.71	14.60
Shares Outstanding	87.13	64.58	53.72	25.27	0.00
Total Stockholders' Equity	345.87	255.37	276.94	160.30	68.59
Total Liabilities & Equity	363.93	268.52	287.03	168.07	92.29